| 1. |
谢长好, 李志军. 系统性红斑狼疮的诊断与治疗[J]. 中华全科医学, 2020, 18(4): 527-528.Xie CH, Li ZJ. Diagnosis and treatment of systemic lupus erythematosus[J]. Chin J Gener Pract, 2020, 18(4): 527-528.
|
| 2. |
Li J, Wang X, Zhang H, et al. Aorta coarctation and systemic lupus erythematosus: a case report[J/OL]. Medicine, 2019, 98(28): e16397[2019-07-01]. https://pubmed.ncbi.nlm.nih.gov/31305448/. DOI: 10.1097/MD.0000000000016397.
|
| 3. |
Dos Santos M, Veronese FV, Moresco RN. Uric acid and kidney damage in systemic lupus erythematosus[J]. Clin Chim Acta, 2020, 508: 197-205. DOI: 10.1016/j.cca.2020.05.034.
|
| 4. |
Lin WV, Saumur M, Al-Mohtaseb Z. Scleritis, keratitis, and orbital cellulitis: isolated ocular manifestation of systemic lupus erythematosus[J]. Lupus, 2018, 27(12): 1985-1988. DOI: 10.1177/0961203318792365.
|
| 5. |
Tsirouki T, Dastiridou AI, Ibánez Flores N, et al. Orbital cellulitis[J]. Surv Ophthalmol, 2018, 63(4): 534-553. DOI: 10.1016/j.survophthal.2017.12.001.
|
| 6. |
Yadalla D, Jayagayathri R, Padmanaban K, et al. Bacterial orbital cellulitis-a review[J]. Indian J Ophthalmol, 2023, 71(7): 2687-2693. DOI: 10.4103/IJO.IJO_3283_22.
|
| 7. |
Talat L, Lightman S, Tomkins-Netzer O. Ischemic retinal vasculitis and its management[J/OL]. J Ophthalmol, 2014, 2014: 197675[2014-03-15]. https://pubmed.ncbi.nlm.nih.gov/24839552/. DOI: 10.1155/2014/197675.
|
| 8. |
Ganne P, Slesser D, Syamala DD. Purtscher-like retinopathy in systemic lupus erythematosus[J]. QJM, 2023, 116(3): 233-234. DOI: 10.1093/qjmed/hcad204.
|
| 9. |
Azevedo LGB, Biancardi AL, Silva RA, et al. Lupus retinopathy: epidemiology and risk factors[J]. Arq Bras Oftalmol, 2021, 84(4): 395-401. DOI: 10.5935/0004-2749.20210076.
|
| 10. |
赵文玲, 苏真珍, 刘萍, 等. 系统性红斑狼疮并发类远达性视网膜病变3例分析[J]. 标记免疫分析与临床, 2024, 31(3): 583-588. DOI: 10.11748/bjmy.issn.1006-1703.2024.03.035.Zhao WL, Su ZZ, Liu P, et al. An analysis of 3 cases of systemic lupus erythematosus complicated by Purtscher-like retinopathy[J]. Labeled Immunoassays & Clin Med, 2024, 31(3): 583-588. DOI: 10.11748/bjmy.issn.1006-1703.2024.03.035.
|
| 11. |
Yusuf IH, Sharma S, Luqmani R, et al. Hydroxychloroquine retinopathy[J]. Eye, 2017, 31(6): 828-845. DOI: 10.1038/eye.2016.298.
|
| 12. |
Trefond L, Lhote R, Mathian A, et al. Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patients[J/OL]. Semin Arthritis Rheum, 2024, 66: 152417[2024-02-12]. https://pubmed.ncbi.nlm.nih.gov/38394986/. DOI: 10.1016/j.semarthrit.2024.152417.
|
| 13. |
Lee JH, Jeon HW, Moon SJ, et al. Treatment of various ocular manifestation of systemic lupus erythematosus with therapeutic plasma exchange[J]. J Clin Med, 2022, 11(22): 6632. DOI: 10.3390/jcm11226632.
|
| 14. |
中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志, 2020, 59(3): 172-185. DOI: 10.3760/cma.j.issn.0578-1426.2020.03.002.Chinese Society of Rheumatology, National Clinical Medical Research Center for Skin and Immune Diseases, China Systemic Lupus Erythematosus Research Collaboration Group. 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus[J]. Chin J Intern Med, 2020, 59(3): 172-185. DOI: 10.3760/cma.j.issn.0578-1426.2020.03.002.
|
